Outcome and prognostic factors in hiv-1-infected patients on dialysis in the cART Era: A GESIDA/SEN cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 4, 2011, Pages 276-283

  Trullàs, Joan Carles ^a   Cofan, Federico ^b   Barril, Guillermina ^c   Martínez Castelao, Alberto ^b   Jofre, Rosa ^d   Rivera, Maite ^e   Martínez Ara, Jorge ^f   Ros, Silvia ^g   Perez, Iñaki ^b   Moreno, Asunción ^b   Miró, Jose M ^b  

^a UNIVERSITY OF GIRONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

dialysis; end stage renal disease; HIV infection; survival

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HEMODIALYSIS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; SPAIN; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 79959924551     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318221fbda     Document Type: Article

References (36)

1. Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51-59. (Pubitemid 351920404)
2. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-1671. (Pubitemid 34921112)
3. Wyatt CM, Klotman PE. HIV-associated nephropathy in the era of antiretroviral therapy. Am J Med. 2007;120:488-492. (Pubitemid 46764627)
4. Rö ling J, Schmid H, Fischereder M, et al. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis. 2006;42:1488-1495.
5. Casanova S, Mazzucco G, Barbiano di Belgiojoso G, et al. Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study. Am J Kidney Dis. 1995;26:446-453.
6. Kimmel PL, Barisoni L, Kopp JB. Pathogenesis and treatment of HIVassociated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med. 2003;139:214-226. (Pubitemid 38124604)
7. Trullàs JC, Cofan F, Tuset M, et al. Renal transplantation in HIV-infected patients: 2010 update. Kidney Int. 2011;79:825-842.
8. Ortiz C, Meneses R, Jaffe D, et al. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int. 1988; 34:248-253.
9. Abbott KC, Hypolite I, Welch PG, et al. Human immunodeficiency virus/ acquired immunodeficiency syndrome-associated nephropathy at endstage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol. 2001;14: 377-383. (Pubitemid 33080979)
10. Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002;13:1889-1893. (Pubitemid 34700614)
11. Rodriguez RA, Mendelson M, O'Hare AM, et al. Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol. 2003;14:1307-1313. (Pubitemid 36514670)
12. Ahuja TS, Borucki M, Grady J. Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis. 2000;36:574-580.
13. Atta MG, Fine DM, Kirk GD, et al. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis. 2007;45:1625-1632. (Pubitemid 351411849)
14. Trullàs JC, Barril G, Cofan F, et al. Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses. 2008;24:1229-1235.
15. Geerlings W, Tufveson G, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XXI, 1990. Nephrol Dial Transplant. 1991;6(suppl 4):5-29.
16. Pintilie M. Competing Risks. A Practical Perspective. West Sussex, United Kingdom: John Wiley & Songs, Ltd; 2006.
17. R Development Core Team. R: A Language and Environment for Statistical Computing, Reference Index Version 2.2.1. Vienna, Austria: R Foundation for Statistical Computing; 2005. Available at: http://www. R-project.org. Accessed May 31, 2011.
18. Tourret J, Tostivint I, du Montcel ST, et al. Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol. 2006;1: 1241-1247.
19. Mazuecos A, Fernández A, Andrés A, et al. HIV infection and renal transplantation. Nephrol Dial Transplant. 2011;26:1401-1407.
20. Bansi L, Hughes A, Bhagani S, et al. Clinical epidemiology of HIVassociated end-stage renal failure in the UK. AIDS. 2009;23:2517-2521.
21. Cnossen TT, Konings CJ, Kooman JP, et al. Peritoneal sclerosis- aetiology, diagnosis, treatment and prevention. Nephrol Dial Transplant. 2006;21(suppl 2):ii38-ii41. (Pubitemid 44018943)
22. Rivera M, Martins J, Tenorio MT, egt al. Quiz page. A peritoneal dialysis patient with HIV infection and abdominal pain: massive sclerosing encapsulating peritonitis. Am J Kidney Dis. 2007;50:A51-A52.
23. Mesquita M, Guillaume MP, Dratwa M. First use of tamoxifen in an HIV patient with encapsulating peritoneal sclerosis. Clin Drug Investig. 2007; 27:727-729. (Pubitemid 47481705)
24. Kimmel PL, Umana WO, Simmens SJ, et al. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int. 1993;44:373-378. (Pubitemid 23228693)
25. Ahuja TS, Collinge N, Grady J, et al. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy? Am J Kidney Dis. 2003;41:1060-1064. (Pubitemid 36532141)
26. Weinhandl ED, Foley RN, Gilbertson DT, et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010;21:499-506.
27. Lin X, Lin A, Ni Z, et al. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant. 2010;25:2322-2327.
28. Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant. 2009; 24:2909-2914.
29. Tebben JA, Rigsby MO, Selwyn PA, et al. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int. 1993;44:191-198. (Pubitemid 23198043)
30. Kimmel PL, Barisoni L,Kopp JB. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations.Ann Intern Med. 2003;139:214-226. (Pubitemid 38124604)
31. Mokrzycki MH, Schröppel B, von Gersdorff G, et al. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol. 2000;11:2122-2127.
32. Mitchell D, Krishnasami Z, Allon M. Catheter-related bacteraemia in haemodialysis patients with HIV infection. Nephrol Dial Transplant. 2006;21:3185-3188. (Pubitemid 44567091)
33. Sawinski D, Wyatt CM, Casagrande L, et al. Factors associated with failure to list HIV-positive kidney transplant candidates. Am J Transplant. 2009;9:1-5.
34. Trullas JC, Mocroft A, Cofan F, et al. Dialysis and renal transplantation in HIV-infected patients: a European survey. J Acquir Immune Defic Syndr. August 31, 2010 [Epub ahead of print].
35. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363:2004-2014.
36. Miró JM, Torre-Cisnero J, Moreno A, et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005). Enferm Infecc Microbiol Clin. 2005;23:353-362 (Pubitemid 41020547)